Relative Bioavailability of a Linagliptin+Metformin Fixed Dose Combination Tablet Administered With and Without Food to Healthy Male and Female Subjects

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Study to investigate the effect of food on the relative bioavailability of a 2.5 mg linagliptin+1000 mg metformin fixed dose combination (FDC) tablet

Phase 1

Boehringer Ingelheim

Linagliptin
Metformin